TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Escherichia Coli Therapy
Study findings from S. Arcidiacono et al broaden understanding of Escherichia coli therapy
July 15th, 2008
New research, 'Cy5 labeled antimicrobial peptides for enhanced detection of Escherichia coli O157:H7,' is the subject of a report. According to recent research from the United States, "Fluorescently labeled antimicrobial peptides were evaluated as a potential replacement of labeled antibodies in a sandwich assay for the detection of Escherichia coli O157:H7. Antimicrobial peptides naturally bind to the lipopolysaccharide component of bacterial cell walls as part of their mode of action." "Because of their small size relative to antibodies peptides can bind to cell surfaces with greater density, thereby increasing the optical signal and improving sensitivity. This...
Source: TB & Outbreaks Week (2008-07-15)
|
